缩写名/全名 |
CANCER SCI
CANCER SCIENCE |
||||||||||||||||||||
ISSN号 | 1347-9032 | ||||||||||||||||||||
研究方向 | 医学-肿瘤学 | ||||||||||||||||||||
影响因子 | 2015:3.896, 2016:3.974, 2017:4.372, 2018:4.751, 2019:4.966, | ||||||||||||||||||||
出版国家 | JAPAN | ||||||||||||||||||||
出版周期 | Monthly | ||||||||||||||||||||
年文章数 | 345 | ||||||||||||||||||||
出版年份 | 2003 | ||||||||||||||||||||
是否OA | Yes | ||||||||||||||||||||
审稿周期(仅供参考) | 平均2.0个月 |
||||||||||||||||||||
录用比例 | 约62.5% | ||||||||||||||||||||
投稿链接 | http://mc.manuscriptcentral.com/cas | ||||||||||||||||||||
投稿官网 | http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1349-7006 | ||||||||||||||||||||
h-index | 129 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1347-9032%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30. Author: Guo Z, Cao M, You A, Gao J, Zhou H, Li H, Cui Y, Fang F, Zhang W, Song T, Li Q, Zhu X, Sun H, Zhang T. Journal: Cancer Sci. 2016 Apr;107(4):507-13. doi: 10.1111/cas.12885. Epub 2016 Feb 23. PubMed |
2. | Nimotuzumab plus paclitaxel and cisplatin as the first line treatment for advanced esophageal squamous cell cancer: A single centre prospective phase II trial. Author: Lu M, Wang X, Shen L, Jia J, Gong J, Li J, Li J, Li Y, Zhang X, Lu Z, Zhou J, Zhang X. Journal: Cancer Sci. 2016 Apr;107(4):486-90. doi: 10.1111/cas.12894. Epub 2016 Mar 28. PubMed |
3. | MicroRNA-761 is upregulated in hepatocellular carcinoma and regulates tumorigenesis by targeting Mitofusin-2. Author: Zhou X, Zhang L, Zheng B, Yan Y, Zhang Y, Xie H, Zhou L, Zheng S, Wang W. Journal: Cancer Sci. 2016 Apr;107(4):424-32. doi: 10.1111/cas.12904. Epub 2016 Mar 30. PubMed |
4. | Genetic variation frequencies in Wilms' tumor: A meta-analysis and systematic review. Author: Deng C, Dai R, Li X, Liu F. Journal: Cancer Sci. 2016 May;107(5):690-9. doi: 10.1111/cas.12910. Epub 2016 Mar 18. PubMed |
5. | Y-632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo. Author: Wang W, Liu Y, Zhao Z, Xie C, Xu Y, Hu Y, Quan H, Lou L. Journal: Cancer Sci. 2016 Jun;107(6):782-90. doi: 10.1111/cas.12934. Epub 2016 Apr 27. PubMed |
6. | Cisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancer. Author: Zhang F, Duan S, Tsai Y, Keng PC, Chen Y, Lee SO, Chen Y. Journal: Cancer Sci. 2016 Jun;107(6):746-54. doi: 10.1111/cas.12937. Epub 2016 May 3. PubMed |
7. | Metabonomic changes from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma in tissues from rats. Author: Wen S, Li Z, Feng J, Bai J, Lin X, Huang H. Journal: Cancer Sci. 2016 Jun;107(6):836-45. doi: 10.1111/cas.12939. Epub 2016 May 17. PubMed |
8. | UICC International Session: What are the implications of sharing the concept of Universal Health Coverage for cancer in Asia? Author: Akaza H, Roh JK, Hao X, Wibulpolprasert S, Nozaki S, Park EC, Fukuda T, Sonoda S, Kawahara N. Journal: Cancer Sci. 2016 Apr;107(4):556-63. doi: 10.1111/cas.12900. PubMed |
9. | MicroRNA-124-3p regulates cell proliferation, invasion, apoptosis, and bioenergetics by targeting PIM1 in astrocytoma. Author: Deng D, Wang L, Chen Y, Li B, Xue L, Shao N, Wang Q, Xia X, Yang Y, Zhi F. Journal: Cancer Sci. 2016 Jul;107(7):899-907. doi: 10.1111/cas.12946. Epub 2016 Jun 21. PubMed |
10. | B7-H4 facilitates proliferation of esophageal squamous cell carcinoma cells through promoting interleukin-6/signal transducer and activator of transcription 3 pathway activation. Author: Chen X, Wang L, Wang W, Zhao L, Shan B. Journal: Cancer Sci. 2016 Jul;107(7):944-54. doi: 10.1111/cas.12949. Epub 2016 May 27. PubMed |
|
|